Novozymes A/S Stock Price, News & Analysis (OTCMKTS:NVZMY)

$55.01 -0.06 (-0.11 %)
(As of 01/18/2018 04:53 AM ET)
Previous Close$55.31
Today's Range$54.85 - $55.31
52-Week Range$34.38 - $57.84
Volume22,464 shs
Average Volume15,373 shs
Market Capitalization$13.98 billion
P/E Ratio35.26
Dividend Yield0.66%
Beta1.08

About Novozymes A/S (OTCMKTS:NVZMY)

Novozymes A/S logoNovozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

Receive NVZMY News and Ratings via Email

Sign-up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorBasic Materials
SymbolOTCMKTS:NVZMY
CUSIPN/A
Phone45-4446-0000

Debt

Debt-to-Equity RatioN/A
Current Ratio1.48%
Quick Ratio0.86%

Price-To-Earnings

Trailing P/E Ratio35.2628205128205
Forward P/E Ratio32.55
P/E Growth2.41

Sales & Book Value

Annual Sales$2.10 billion
Price / Sales6.58
Cash Flow$1.75 per share
Price / Cash31.45
Book Value$6.81 per share
Price / Book8.08

Profitability

Trailing EPS$1.56
Net Income$453.23 million
Net Margins21.52%
Return on Equity28.25%
Return on Assets16.92%

Miscellaneous

Employees6,441
Outstanding Shares251,260,000

Novozymes A/S (OTCMKTS:NVZMY) Frequently Asked Questions

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How were Novozymes A/S's earnings last quarter?

Novozymes A/S - (OTCMKTS:NVZMY) issued its earnings results on Wednesday, October, 25th. The biotechnology company reported $0.44 earnings per share for the quarter. The biotechnology company earned $565.32 million during the quarter. Novozymes A/S had a return on equity of 28.25% and a net margin of 21.52%. View Novozymes A/S's Earnings History.

Where is Novozymes A/S's stock going? Where will Novozymes A/S's stock price be in 2018?

3 analysts have issued 1 year price objectives for Novozymes A/S's stock. Their predictions range from $54.97 to $54.97. On average, they anticipate Novozymes A/S's share price to reach $54.97 in the next year. View Analyst Ratings for Novozymes A/S.

Who are some of Novozymes A/S's key competitors?

Who are Novozymes A/S's key executives?

Novozymes A/S's management team includes the folowing people:

  • Joergen Buhl Rasmussen, Chairman of the Board (Age 62)
  • Peder Holk Nielsen, President, Chief Executive Officer (Age 60)
  • Agnete Raaschou-Nielsen, Vice Chairman of the Board (Age 60)
  • Thomas Videbaek, Chief Operating Officer; Executive Vice President, Research, Innovation & Supply (Age 56)
  • Andrew Fordyce, Executive Vice President, Food & Beverages (Age 54)
  • Anders Lund, Executive Vice President, Household Care & Technical (Age 44)
  • Tina Sejersgaard Fanoe, Executive Vice President, Agriculture & Bioenergy (Age 48)
  • Lena Bech Halskov, Director, Employee Representative (Age 50)
  • Lars Hall Green, Director (Age 50)
  • Anders Hentze Knudsen, Director, Employee Representative (Age 58)

How do I buy Novozymes A/S stock?

Shares of Novozymes A/S can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Novozymes A/S's stock price today?

One share of Novozymes A/S stock can currently be purchased for approximately $55.01.

How big of a company is Novozymes A/S?

Novozymes A/S has a market capitalization of $13.98 billion and generates $2.10 billion in revenue each year. The biotechnology company earns $453.23 million in net income (profit) each year or $1.56 on an earnings per share basis. Novozymes A/S employs 6,441 workers across the globe.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, Bagsvaerd G7, 2880. The biotechnology company can be reached via phone at 45-4446-0000 or via email at [email protected]


MarketBeat Community Rating for Novozymes A/S (NVZMY)

Community Ranking:  1.2 out of 5 (star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  115
MarketBeat's community ratings are surveys of what our community members think about Novozymes A/S and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Novozymes A/S (OTCMKTS:NVZMY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.672.002.002.00
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $54.97$54.97$48.00$47.50
Price Target Upside: 1.61% upside1.61% upside5.49% upside13.20% upside

Novozymes A/S (OTCMKTS:NVZMY) Consensus Price Target History

Price Target History for Novozymes A/S (OTCMKTS:NVZMY)

Novozymes A/S (OTCMKTS:NVZMY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/26/2017Jefferies GroupReiterated RatingHold$54.97View Rating Details
2/10/2017JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details
2/1/2017Goldman Sachs GroupDowngradeNeutral -> SellView Rating Details
1/5/2017Sanford C. BernsteinUpgradeMkt Perform -> OutperformView Rating Details
11/1/2016Berenberg BankUpgradeSell -> HoldView Rating Details
10/7/2016Deutsche BankInitiated CoverageHoldView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Novozymes A/S (OTCMKTS:NVZMY) Earnings History and Estimates Chart

Earnings by Quarter for Novozymes A/S (OTCMKTS:NVZMY)

Novozymes A/S (OTCMKTS NVZMY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017Q3 2017$0.44$565.32 millionViewN/AView Earnings Details
8/11/2017Q2 2017$0.39$0.36$522.72 millionViewN/AView Earnings Details
4/26/20173/31/2017$0.36$0.37$535.97 millionViewN/AView Earnings Details
1/18/2017Q4 2016$0.39ViewN/AView Earnings Details
10/27/2016Q3 2016$0.37ViewN/AView Earnings Details
8/10/2016Q2 2016$0.37ViewN/AView Earnings Details
4/20/2016Q1 2016$0.36ViewN/AView Earnings Details
1/19/2016Q4 2015$0.31$0.33ViewN/AView Earnings Details
10/22/2015$0.36$0.36ViewN/AView Earnings Details
8/6/2015$0.35$0.33ViewN/AView Earnings Details
4/24/2015$0.33$0.33ViewN/AView Earnings Details
1/20/2015$0.23$0.30ViewN/AView Earnings Details
10/27/2014$0.35$0.34ViewN/AView Earnings Details
8/15/2014$0.38$0.34ViewN/AView Earnings Details
5/20/2014$0.33$0.40ViewN/AView Earnings Details
4/24/2014Q1 2014$0.33$0.40ViewN/AView Earnings Details
1/21/2014Q4 2013$0.33$0.31ViewN/AView Earnings Details
10/25/2013Q3 2013$0.33ViewN/AView Earnings Details
8/9/2013Q2 2013$0.31ViewN/AView Earnings Details
4/25/2013Q1 2013$0.29$0.28ViewN/AView Earnings Details
1/21/2013Q4 2012$0.29$0.27ViewN/AView Earnings Details
10/25/2012Q3 2012$0.28ViewN/AView Earnings Details
8/16/2012Q2 2012$0.27$0.25ViewN/AView Earnings Details
4/25/2012Q1 2012$0.25$0.28ViewN/AView Earnings Details
1/19/2012Q4 2011$0.21$0.20ViewN/AView Earnings Details
10/28/2011Q3 2011$0.27$0.31ViewN/AView Earnings Details
8/11/2011Q2 2011$0.29$0.27ViewN/AView Earnings Details
4/29/2011Q1 2011$0.27$0.28ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Novozymes A/S (OTCMKTS:NVZMY) Earnings Estimates

Current Year EPS Consensus Estimate: $1.69 EPS
Next Year EPS Consensus Estimate: $1.85 EPS

Dividends

Dividend History for Novozymes A/S (OTCMKTS:NVZMY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novozymes A/S (OTCMKTS NVZMY)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Novozymes A/S (OTCMKTS NVZMY) News Headlines

Source:
DateHeadline
Novozymes A/S (NVZMY) Downgraded to Hold at Zacks Investment ResearchNovozymes A/S (NVZMY) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - December 28 at 11:42 PM
ETFs with exposure to Novozymes A/S : November 2, 2017ETFs with exposure to Novozymes A/S : November 2, 2017
finance.yahoo.com - November 4 at 8:18 AM
Novozymes A/S :NVZMY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Novozymes A/S :NVZMY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 2 at 7:09 AM
Novozymes A/S :NVZMY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Novozymes A/S :NVZMY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 2 at 7:09 AM
Novozymes shares surge as bioenergy tops expectationsNovozymes shares surge as bioenergy tops expectations
finance.yahoo.com - October 25 at 8:28 AM
Novozymes A/S (NVZMY) to Release Quarterly Earnings on WednesdayNovozymes A/S (NVZMY) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - October 18 at 6:24 AM
Novozymes A/S :NVZMY-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017Novozymes A/S :NVZMY-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017
finance.yahoo.com - August 22 at 1:08 AM
Novozymes shares fall as Q2 pressured by detergent makers, Monsanto allianceNovozymes shares fall as Q2 pressured by detergent makers, Monsanto alliance
finance.yahoo.com - August 11 at 7:07 AM
Novozymes A/S reports 1H resultsNovozymes A/S reports 1H results
seekingalpha.com - August 11 at 6:20 AM
Novozymes A/S (NVZMY) to Release Earnings on FridayNovozymes A/S (NVZMY) to Release Earnings on Friday
www.americanbankingnews.com - August 4 at 7:12 AM
Are microbes the next revolution coming to Big Ag?Are microbes the next revolution coming to Big Ag?
www.marketwatch.com - January 28 at 5:20 AM
Novozymes upgraded by JP MorganNovozymes upgraded by JP Morgan
us.rd.yahoo.com - December 9 at 6:53 PM
Kerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient Market - Seeking AlphaKerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient Market - Seeking Alpha
seekingalpha.com - January 30 at 1:44 PM
Novozymes profit up; sees moderate growth in 2016 - MarketWatchNovozymes profit up; sees moderate growth in 2016 - MarketWatch
www.marketwatch.com - January 19 at 12:34 PM
Novozymes profit up; sees moderate growth in 2016Novozymes profit up; sees moderate growth in 2016
www.marketwatch.com - January 19 at 12:34 PM
European Stocks Rise on Climb in German Investor ConfidenceEuropean Stocks Rise on Climb in German Investor Confidence
www.thestreet.com - January 20 at 6:24 AM

SEC Filings

Novozymes A/S (OTCMKTS:NVZMY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Novozymes A/S (OTCMKTS NVZMY) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.